Target intelligence / Profile preview

TOPLESS (TPL)

Target
TPL
Molecular classification
Transcription factor, Corepressor, LisH-domain protein, WD40-repeat protein
01

Overview

TOPLESS (TPL) is a foundational transcriptional corepressor in plants, primarily characterized in the model organism Arabidopsis thaliana. It is a member of the evolutionarily conserved Groucho/Tup1 family, which includes human homologs such as Transducin-like enhancer of split (TLE) and Transducin beta-like 1 (TBL1) [7.2.1, 7.3.1]. TPL acts as a central hub in multiple plant signaling pathways, including those for auxin, jasmonate, and strigolactone, by bridging DNA-binding transcription factors with chromatin-remodeling machinery [7.5.1, 9.2.1]. It typically interacts with repressors containing an Ethylene-responsive element binding factor-associated Amphiphilic Repression (EAR) motif through its N-terminal LisH and CTLH domains [7.1.2, 8.2.2]. While TPL is not a direct therapeutic target in human medicine, it is extensively utilized in synthetic biology and drug discovery research, particularly as a critical component of the auxin-inducible degron (AID) system for targeted protein degradation in mammalian cells [7.1.1, 8.5.3].

Other names
TPLTOPLESS-relatedTPRAtTPLGroucho/Tup1-like corepressor
02

Mechanism of action

Recruits histone deacetylases (HDACs) and interacts with the Mediator complex (specifically Med21 and Med10) to inhibit RNA polymerase II-mediated transcription initiation and elongation [7.2.1, 8.2.1].

03

Biological functions

Transcriptional repressionAuxin signalingJasmonate signalingPlant developmentCircadian rhythm regulation
04

Disease associations

Plant developmental defectsPathogen susceptibility
05

Safety considerations

Not a human protein; no known safety concerns in humansPotential for off-target effects in synthetic biology applications

Beyond the preview

Go deeper on TOPLESS (TPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOPLESS (TPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call